tert-butylhydroperoxide has been researched along with glucagon-like peptide 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brindamour, LJ; Habener, JF; Liu, Z; Stanojevic, V | 1 |
| Álvarez, C; Escrivá, F; Fernández-Millán, E; Goya, L; Lizárraga-Mollinedo, E; Martín, MA; Ramos, S | 1 |
2 other study(ies) available for tert-butylhydroperoxide and glucagon-like peptide 1
| Article | Year |
|---|---|
GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity.
Topics: Adenosine Triphosphate; Apoptosis; Cell Survival; Cells, Cultured; Diabetes Mellitus, Type 2; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Hydrogen Peroxide; Insulin; Insulin Secretion; Insulin-Secreting Cells; Membrane Potential, Mitochondrial; Oleic Acid; Oxidative Stress; Peptide Fragments; Peptides; Receptors, Glucagon; tert-Butylhydroperoxide; Venoms | 2012 |
Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation.
Topics: Animals; Antioxidants; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Type 2; Extracellular Signal-Regulated MAP Kinases; Glucagon-Like Peptide 1; Glucose; Glutathione; Glutathione Reductase; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Isoquinolines; NF-E2-Related Factor 2; Oxidative Stress; Rats; Reactive Oxygen Species; Sulfonamides; tert-Butylhydroperoxide; Uncoupling Protein 2 | 2016 |